Amino acid neurotransmitters in sarcopenia and healthy aging.

Steffi M Jonk, James R Tribble, Peter Swoboda, Pete A Williams

Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden.Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden. · pubmed

Paper

Abstract

Sarcopenia is the age-related degeneration of skeletal muscle. Healthy skeletal muscle secretes metabolites and macromolecules that are systemically important for the immune system (e.g. myokines) and the central nervous system (e.g. BDNF). Exercise interventions to stimulate skeletal muscle are therapeutic for sarcopenia and limit risk and/or provide neuroprotection in neurodegenerative disease models. Metabolic analysis of aged skeletal muscle has identified altered skeletal muscle metabolomes at an old age. Many of the molecules identified are amino acids that also act as neurotransmitters. In this review, we summarize how 13 amino acids act as neurotransmitters or as precursor to neurotransmitters, and how these are involved in the skeletal muscle secretome, sarcopenia, and (healthy) aging.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims that 13 amino acids function as neurotransmitters and are involved in the skeletal muscle secretome, influencing sarcopenia and healthy aging. The focus on amino acid neurotransmitters in relation to skeletal muscle and aging provides insights into potential mechanisms underlying age-related muscle degeneration, which is relevant to understanding and addressing the root causes of aging.

Author of this paper? Send a correction.